As proving MAE remains huge undertaking, Advent snags Forescout at a discount

While the highly anticipated MAE trial is called off, Advent's revised agreement for Forescout narrows from $1.9bn to to $1.43bn. 

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this